Marlowe has produced a strong set of results for H1/20A, with improved cross-selling helping drive an acceleration in organic revenue growth to +6.5% YoY. With H2/20E starting well, we upgrade our FY20E and FY21E forecasts to account for this improved growth trajectory, along with the impact of recent acquisitions. Buy.